DPA and HRI condemn the US' multibillion-dollar contribution to punitive responses, urging greater transparency and a commitment to a rights-based approach.
The Global Commission on Drug Policy exposes prohibitionist policies' role in fueling inequities and offers a roadmap for reform including harm reduction measures, decriminalsiation, and the legal regulation of drug markets,
Jallal Toufiq underscored the need to overcome disparities in access to controlled medicines and treatment services, prioritising health and alternatives to punishment.
IDPC marks Human Rights Day 2024 by shining a light on setbacks, key progress and promising avenues to better align drug policies and human rights standards.
HRI and DPA extend an invitation to a launch webinar showcasing their recent report, which analyses harms caused by US international drug control spending.
The resolution's veneer of consensus betrays deepening fractures in global drug policy debates, as demonstrated by the string of 'disassociation' statements that followed the document's adoption.
Organisations worldwide urge UNODC's Executive Director to mark International Human Rights Day 2024 by calling on Member States to align drug policies and practices with human rights, and commit to placing human rights at the centre of all dimensions of the UNODC’s work.
IDPC co-signs joint statement at the 57th session of the Human Rights Council urging sentencing reform for drug offences, including abolishing the death penalty and mandatory sentences.